J. Schloos

发表

Reproducibility and consistency of the responses to supine bicycle ergometry; evaluation in conjunction with beta 1-adrenoceptor occupancies.

K. Breithaupt-Grögler, G. Belz, C. D. De Mey, 1994, British journal of clinical pharmacology.

Binding properties of somatostatin receptor subtypes.

D. Hoyer, F. Raulf, H. Lübbert, 1996, Metabolism: clinical and experimental.

Identification and pharmacological characterization of somatostatin receptors in rat lung

D. Hoyer, F. Raulf, J. Schloos, 1997, British journal of pharmacology.

Dose‐effect and pharmacokinetic‐pharmacodynamic relationships of the β1adrenergic receptor blocking properties of various doses of carvedilol in healthy humans

G. Neugebauer, G. Belz, C. Mey, 1994, Clinical pharmacology and therapeutics.

The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients

S. Jakob, E. Mutschler, K. Weisser, 2005, European Journal of Clinical Pharmacology.

Agonist binding at alpha2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations

A. Wellstein, J. Schloos, D. Palm, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies.

W. Kukovetz, E. Kühberger, F. Brunner, 1991, European journal of pharmacology.

Measurement of Carvedilol Enantiomers in Human Plasma and Urine Using S‐Naproxen Chloride for Chiral Derivatization

P. Langguth, E. Mutschler, J. Schloos, 1990, Archiv der Pharmazie.

Oral administration of carvedilol and prazosin inhibits the prostaglandin F2α- and noradrenaline-induced contraction of human hand veins in vivo

G. Belz, J. Schloos, C. Beermann, 2004, The clinical investigator.

Agonist Interaction with α2-Adrenoceptors of Human Platelets

J. Schloos, D. Palm, 1986 .

Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects

H. Vetter, R. Düsing, E. Mutschler, 2004, European Journal of Clinical Pharmacology.

Constriction of human dorsal hand veins in vivo with several vasoconstrictors and the influence of oral administration of carvedilol.

G. Belz, J. Schloos, C. Beermann, 1992, Journal of cardiovascular pharmacology.

Investigations of the mechanism of the positive inotropic action of BDF 9148: comparison with DPI 201-106 and the enantiomers.

B. Armah, J. Schloos, W. Stenzel, 1997, Journal of cardiovascular pharmacology.

Different Modes of Action of the Imidazoline Compound RX871024 in Pancreatic β‐Cells: Blocking of K+ Channels, Mobilization of Ca2+ from Endoplasmic Reticulum, and Interaction with Exocytotic Machinery a

O. Larsson, P. Berggren, S. Efendić, 1999, Annals of the New York Academy of Sciences.

Measurements of serum ACE activity in vitro after administration of enalapril in man cannot reflect inhibition of the enzyme in vivo.

K. Weisser, J. Schloos, 1993, Methods and findings in experimental and clinical pharmacology.

Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line* * This work was supported by grants from the Canadian Diabetes Association (Margaret A. Mollet grant, to P.L.B.) and Eli Lilly.

D. Drucker, P. Brubaker, D J Drucker, 1998, Endocrinology.

The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro.

K. Weisser, J. Schloos, 1991, Biochemical pharmacology.

Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line* * This work was supported by grants from the Canadian Diabetes Association (Margaret A. Mollet grant, to P.L.B.) and Eli Lilly.

D. Drucker, P. Brubaker, J. Schloos, 1998, Endocrinology.

Glucose-induced insulin secretion is potentiated by a new imidazoline compound

V. Koivisto, J. Schloos, M. Paal, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.